Group Chief Executive: | Greg Madison |
Independent Non-Executive Director: | Peter Llewellyn-Davies |
Independent Non-Executive Director: | Anders Lundstrom |
Independent Non-Executive Director: | Fabiana Lacerca Allen |
Non-Executive Chairman: | Hans-Peter Hasler |
Non-Executive Dir: | Christian Schweiger |
Address: | Northern Design Centre, Baltic Business Quarter, Gateshead Quays, United Kingdom, NE8 3DF |
Phone: | +44 (0) 191 511 8500 |
Website: | http://www.shieldtherapeutics.com/ |
Sector: | Pharma and Biotech(LSE) |
Index: | FTSE AIM All-Share |
ISIN: | GB00BYV81293 |
Currency | UK Pounds |
Share Price | 2.03p |
Change Today | 0.025p |
% Change | 1.25 % |
52 Week High | 12.50 |
52 Week Low | 1.98 |
Volume | 632,383 |
Shares Issued | 782.06m |
Market Cap | £15.84m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 0 |
Buy | 1 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 1 |
No dividends found |
Time | Volume / Share Price |
16:22 | 4,500 @ 2.05p |
15:40 | 200 @ 2.05p |
15:40 | 487 @ 2.05p |
15:36 | 30,000 @ 2.03p |
15:33 | 4,357 @ 1.99p |
You are here: research